Gland Pharma Limited has submitted a confirmation certificate for the quarter ended December 31, 2025, as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate was received from MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent.

The certificate confirms that securities received from depository participants for dematerialisation during the quarter were processed and confirmed with the depositories. It also states that the securities were listed on the respective stock exchanges, and the certificates were mutilated and cancelled after verification, with the depositories' names substituted in the register of members within the stipulated timelines.

MUFG Intime India Private Limited noted that no requests for dematerialization or rematerialization were received during the period. The announcement serves as an update for regulatory compliance and record-keeping purposes.